Copernicus Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-42,186
Closed -$5.75M – 22
2020
Q3
$5.75M Sell
42,186
-14,814
-26% -$1.58M 5.48% 8
2020
Q2
$5.51M Buy
+57,000
New +$4.75M 6.04% 8

Copernicus Capital Management's MYOK Position: Q4 2020 in Review

Copernicus Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 42,186 shares — an estimated $5.75M sold.

Copernicus Capital Management first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $5.75M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Copernicus Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Copernicus Capital Management sold 42,186 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.75M.
  • Copernicus Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Copernicus Capital Management's MyoKardia, Inc. Common Stock position peaked at $5.75M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Copernicus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.